Increased epithelial permeability in pulmonary fibrosis in relation to disease progression von GOH, N. S. L, DESAI, S. R, ANAGNOSTOPOULOS, C, HANSELL, D. M, HOYLES, R. K, SATO, H, DENTON, C. P, BLACK, C. M, DU BOIS, R. M, WELLS, A. U

Volltext

P274 Anti-synthetase Syndrome: Validity Of Ana As A Screening Tool – The Oxford Ild Service Experience von Nicholson, TW, Woods, A, David, J, Hoyles, R

Volltext

Outcome of Hospitalization for COVID-19 in Patients with Interstitial Lung Disease. An International Multicenter Study von Drake, Thomas M, Docherty, Annemarie B, Harrison, Ewen M, Quint, Jennifer K, Adamali, Huzaifa, Agnew, Sarah, Babu, Suresh, Barber, Christopher M, Barratt, Shaney, Bendstrup, Elisabeth, Bianchi, Stephen, Villegas, Diego Castillo, Chaudhuri, Nazia, Chua, Felix, Coker, Robina, Chang, William, Crawshaw, Anjali, Crowley, Louise E, Dosanjh, Davinder, Fiddler, Christine A, Forrest, Ian A, George, Peter M, Gibbons, Michael A, Groom, Katherine, Haney, Sarah, Hart, Simon P, Heiden, Emily, Henry, Michael, Ho, Ling-Pei, Hoyles, Rachel K, Hutchinson, John, Hurley, Killian, Jones, Mark, Jones, Steve, Kokosi, Maria, Kreuter, Michael, MacKay, Laura S, Mahendran, Siva, Margaritopoulos, George, Molina-Molina, Maria, Molyneaux, Philip L, O'Brien, Aiden, O'Reilly, Katherine, Packham, Alice, Parfrey, Helen, Poletti, Venerino, Porter, Joanna C, Renzoni, Elisabetta, Rivera-Ortega, Pilar, Russell, Anne-Marie, Saini, Gauri, Spencer, Lisa G, Stella, Giulia M, Stone, Helen, Sturney, Sharon, Thickett, David, Thillai, Muhunthan, Wallis, Tim, Ward, Katie, Wells, Athol U, West, Alex, Wickremasinghe, Melissa, Woodhead, Felix, Hearson, Glenn, Howard, Lucy, Baillie, J Kenneth, Openshaw, Peter J M, Semple, Malcolm G, Stewart, Iain, Jenkins, R Gisli

Volltext

C39 IPF: MORE ON DIAGNOSIS AND THERAPY: Cpi And Dlco Parameters Identifying Patients At Risk Of Acute Exacerbation Of Ipf von Fraser, E, Hoyles, R, Ho, L

Volltext

P123 The Benefits Of Pulmonary Rehabilitation (pr) In Interstitial Lung Disease (ild): Observations From Oxfordshire's Mixed Respiratory Disease, Community Based Pr Programme von Lardner, R., Bolton, S., Hoyles, R.

Volltext

S79 Prevalence of the indeterminate for UIP CT feature and potential link between monocyte and neutrophil levels and progression to IPF – a single centre analysis von Achaiah, A, Rathnapala, A, Pereira, A, Bothwell, H, Dwivedi, K, Barker, R, Iotchkova, V, Hoyles, R, Ho, LP

Volltext

Nintedanib for non-IPF progressive pulmonary fibrosis: 12-month outcome data from a real-world multicentre observational study von Raman, L, Stewart, I, Barrett, S, Chua, F, Chaudhuri, N, Crawshaw, A, Gibbons, M, Hogben, C, Hoyles, R, Kouranos, V, Martinovic, J, Mulholland, S, Myall, K, Naqvi, M, Renzoni, E, Saunders, P, Stewart, M, Suresh, D, Thillai, M, Wells, A, West, A, Mitchell, J, George, P

Volltext

P284 Identifying patients at risk of acute exacerbation of ipf using the cpi score von Fraser, E, Noble, V St, Benamore, R, Hoyles, R, Ho, LP

Volltext

S78 Lymphopaenia and increased ace levels stratify sarcoidosis patients to underlying increase in IFN-[GAMMA] + lymphocyte and TNF-[alpha]+ monocytes respectively von Kendrick, YK, Cole, SL, Hoyles, R, Ho, LP

Volltext

S78Lymphopaenia and increased ace levels stratify sarcoidosis patients to underlying increase in IFN- gamma + lymphocyte and TNF- alpha + monocytes respectively von Kendrick, Y K, Cole, S L, Hoyles, R, Ho, L P

Volltext

S78 Lymphopaenia and increased ace levels stratify sarcoidosis patients to underlying increase in IFN-γ + lymphocyte and TNF-α+ monocytes respectively von Kendrick, YK, Cole, SL, Hoyles, R, Ho, LP

Volltext

Efficacy of tocilizumab for interstitial lung disease in an undifferentiated autoinflammatory disorder partially responsive to anakinra von Keidel, Sarah M., Hoyles, Rachel K., Wilkinson, Nick M. R.

Volltext

S50 Monocytes from IPF patients show pre-conditioned pro-repair features von Fraser, E, Blirando, K, St.Noble, V, Benamore, R, Hoyles, R, Benlahrech, A, Ho, LP

Volltext

P39 CTAS – a ct score to quantify disease activity in pulmonary sarcoidosis von Kendrick, YK, Repapi, E, Helm, E, Cole, SL, Hoyles, R, Benamore, R, Ho, LP

Volltext

P39CTAS - a ct score to quantify disease activity in pulmonary sarcoidosis von Kendrick, Y K, Repapi, E, Helm, E, Cole, S L, Hoyles, R, Benamore, R, Ho, L P

Volltext

M272 Estimated Cost And Payment By Results (pbr) Tariff Reimbursement For Idiopathic Pulmonary Fibrosis Services Across 14 Specialist Providers In England von Hill, C., Nasr, R., Fisher, M., Maher, T., Spiteri, M., Allen, M., Birring, S., Parfrey, H., Hoyles, R., Gibbons, M., Burge, G., Scullion, J., Adams, E., Wickremasinghe, M.

Volltext

P9 Nintedanib for the treatment of Idiopathic Pulmonary Fibrosis – initial clinical experience in a UK cohort von Fletcher, SV, Jones, MG, Renzoni, E, Parfrey, H, Hoyles, R, Spinks, K, Kokosi, M, Kwok, A, Warburton, C, Titmuss, V, Maher, T, Chua, F, Wells, A, Richeldi, L, Spencer, LG

Volltext

Current therapeutic options for systemic sclerosis: IP81. Current Challenges in Scleroderma von Denton, C., Hoyles, R., Coghlan, G., van Laar, J.

Volltext

Biomarkers of extracellular matrix turnover in patients with idiopathic pulmonary fibrosis given nintedanib (INMARK study): a randomised, placebo-controlled study von Maher, TM, Stowasser, S, Nishioka, Y, White, ES, Cottin, V, Noth, I, Selman, M, Rohr, KB, Michael, A, Ittrich, C, Diefenbach, C, Jenkins, RG, Corte, T, Glaspole, I, Holmes, M, Troy, L, Veitch, E, Bondue, B, Dahlqvist, C, Louis, R, Van Meerbeeck, J, Wuyts, W, Bittenglova, R, Kolek, V, Pauk, N, Reiterer, P, Sterclova, M, Kilpeläinen, M, Mäkitaro, R, Myllärniemi, M, Purokivi, M, Rantala, T, Couturaud, F, Israel-Biet, D, Jouneau, S, Kessler, R, Lebargy, F, Marchand-Adam, S, Bollmann, T, Günther, A, Hammerl, P, Kirschner, J, Kirsten, A-M, Kreuter, M, Neurohr, C, Prasse, A, Schönfeld, N, Wiewrodt, R, Attila, S, Balazs, M, Csanky, E, Losonczy, G, Hayashi, H, Homma, S, Inoue, Y, Kitamura, H, Nishiyama, O, Ogura, T, Okamoto, M, Saito, T, Taniguchi, H, Zaizen, Y, Filipowska, M, Jarzemska, A, Pierzchala, W, Piotrowski, W, Sladek, K, Trawinska, E, Kim, YW, Park, JS, Song, JW, Aburto, M, Castillo Villegas, D, Echave-Sustaeta, JM, Garcia Fadul, C, Herrera, S, Moises, J, Molina-Molina, M, Moreno, A, Nieto, A, Rodríguez Nieto, MJ, Rodriguez-Portal, JA, Safont, B, Sellares, J, Valenzuela, C, Adamali, H, Chaudhuri, N, Gibbons, M, Hoyles, R, Maher, T, Parfrey, H, Averill, F, Chambers, S, Ettinger, N, Giessel, G, Jones, LM, Kaye, MG, Oelberg, D, Westerman, JH, Zoz, D

Volltext

P175 Single centre experience of the real-life impact of pirfenidone on lung function in patients with idiopathic pulmonary fibrosis von Rathnapala, A, Fries, A, West, Y, Ho, LP, Hoyles, RK

Volltext